Horm Metab Res 1980; 12(4): 155-158
DOI: 10.1055/s-2007-996229
© Georg Thieme Verlag, Stuttgart · New York

Dose-Dependency and Reproducibility of the Prolactin Response to Metoclopramide

M. Kitaoka, K. Takebe, M. Kobayashi, M. Nakazono, M. Kudo
  • Third Department of Medicine, Hirosaki University School of Medicine, Hirosaki, Japan
Further Information

Publication History

1978

1979

Publication Date:
22 April 2008 (online)

Summary

Six normal volunteers were tested to ascertain the dose-dependency and reproducibility of the prolactin response to metoclopramide. Furthermore, pretreatments with 1-dopa or cyproheptadine were performed. The same subjects also received intravenously 500 μg TRH. The oral administration of 5 mg metoclopramide produced a significant rise in prolactin at 60 min and a maximal elevation at 90 min. The intravenous administration of 5 mg metoclopramide produced a significant increment at 15 min and a maximal prolactin level at 30 min. Peak prolactin levels following i.v. administration of the drug were greater than those after oral administration. Intravenous administration of 1 mg of metoclopramide produced a potential increment in plasma prolactin. Maximal prolactin response to 1 mg i.v. metoclopramide was similar to that found with 500 μg i.v. TRH. Reproducibilities of prolactin response were good in all doses and modes of administration of metoclopramide. Pretreatment with 1-dopa inhibited the metoclopramide-induced prolactin response, but pretreatment with cyproheptadine did not influence the prolactin response to metoclopramide. Metoclopramide is a good and reproducible stimulator of prolactin secretion.

    >